Skip to content
drillr.ai
Sign up

MLTX

MoonLake Immunotherapeutics

NASDAQ · Healthcare · Biotechnology · CH

$15.01
−1.18%
Ask drillr
0
Insider buys (3m)
12
Insider sells (3m)
-$7.4M
Net value (3m)
-16.6%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 29, 2026Reich Kristian · officer: Chief Scientific OfficerSale1,100$20
Jul 23, 2026Reich Kristian · officer: Chief Scientific OfficerSale2,448$20
Jul 23, 2026Reich Kristian · officer: Chief Scientific OfficerSale50,000$20
Jul 21, 2026Reich Kristian · officer: Chief Scientific OfficerSale43,700$20
Jul 20, 2026Reich Kristian · officer: Chief Scientific OfficerSale16,105$20
Jul 13, 2026Santos da Silva Jorge · director, officer: Chief Executive OfficerSale33,936$20
Jul 13, 2026Santos da Silva Jorge · director, officer: Chief Executive OfficerSale68,289$20
Jul 2, 2026Santos da Silva Jorge · director, officer: Chief Executive OfficerSale47,775$20
Jun 23, 2026Bodenstedt Matthias · officer: Chief Financial OfficerSale39,120$22
Jun 22, 2026BVF PARTNERS L P/IL · director, 10 percent owner: A-Award22,195$19
Jun 18, 2026Phillips Andrew John · directorA-Award22,195$19
Jun 18, 2026Bodenstedt Matthias · officer: Chief Financial OfficerSale15,082$20
Jun 18, 2026Bodenstedt Matthias · officer: Chief Financial OfficerSale2,794$20
Jun 18, 2026Loy Spike · directorA-Award22,195$19
Jun 18, 2026Moukheibir Catherine · directorA-Award22,195$19
Jun 18, 2026Xavier Ramnik · directorA-Award22,195$19
Jun 17, 2026Reich Kristian · officer: Chief Scientific OfficerSale50,000$19
May 13, 2026Bodenstedt Matthias · officer: Chief Financial OfficerSale13,653$20
Apr 16, 2026Bodenstedt Matthias · officer: Chief Financial OfficerSale2,426$20
Apr 14, 2026Santos da Silva Jorge · director, officer: Chief Executive OfficerSale51,873$18
Apr 14, 2026Santos da Silva Jorge · director, officer: Chief Executive OfficerSale98,127$18
Apr 10, 2026Bodenstedt Matthias · officer: Chief Financial OfficerSale1,925$20
Apr 10, 2026Bodenstedt Matthias · officer: Chief Financial OfficerSale85,870$19
Apr 2, 2026BVF PARTNERS L P/IL · director, 10 percent owner: Sale1,569,116$17
Apr 2, 2026BVF PARTNERS L P/IL · director, 10 percent owner: Sale248,530$17
Apr 2, 2026BVF PARTNERS L P/IL · director, 10 percent owner: Sale1,932,354$17
Jan 9, 2026Santos da Silva Jorge · director, officer: Chief Executive OfficerA-Award520,342$11
Jan 9, 2026Reich Kristian · officer: Chief Scientific OfficerA-Award520,342$11
Jan 9, 2026Bodenstedt Matthias · officer: Chief Financial OfficerA-Award354,296$0.00
Dec 10, 2025Reich Kristian · officer: Chief Scientific OfficerSale130,000$15
Institutional positioning

13F filings over the trailing two quarters

New 87Increased 120Reduced 91Sold out 17
FilerActionSharesFiled
BVF INC/ILUnchanged16,001,284Aug 14, 2026
BVF INC/ILReduced16,001,284May 15, 2026
Deep Track Capital, LPIncreased6,999,025Aug 14, 2026
DEEP TRACK CAPITAL, LPIncreased6,408,863May 15, 2026
CORMORANT ASSET MANAGEMENT, LPIncreased4,480,433May 15, 2026
T. Rowe Price Investment Management, Inc.New Position4,280,624Aug 14, 2026
JANUS HENDERSON GROUP PLCIncreased3,451,628May 18, 2026
D. E. Shaw & Co., Inc.Increased3,365,507Aug 14, 2026
Cormorant Asset Management, LPReduced3,205,433Aug 14, 2026
Jupiter Topco LLCNew Position3,085,906Aug 14, 2026
Logos Global Management LPIncreased2,675,000Aug 14, 2026
Weiss Asset Management LPIncreased2,581,813Aug 14, 2026
CITADEL ADVISORS LLCIncreased2,457,793Sep 2, 2026
D. E. SHAW & CO., INC.Reduced2,390,661May 15, 2026
CITADEL ADVISORS LLCReduced2,081,728May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 29, 2026